Cardiol Therapeutics Inc (CRDL) poses a Brand-New Opportunity for Investors with beta value of 0.95
Witnessing the stock’s movement on the chart, on Thursday, Cardiol Therapeutics Inc (NASDAQ: CRDL) set off with pace as it heaved 7.25% to $2.07, before